About Molecular Infusions
Molecular Infusions is a company based in Los Angeles (United States) founded in 2016 was acquired by Surterra Wellness in June 2019.. Molecular Infusions operates in a competitive market with competitors including Sanity Group, ZYUS Life Sciences, Terraflos, Avicanna and Tetra Bio-Pharma, among others.
- Headquarter Los Angeles, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Surterra Wellness
(Jun 25, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Molecular Infusions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Molecular Infusions
Molecular Infusions has secured backing from 1 investor. Prominent investors backing the company include Surterra. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical cannabis is cultivated and processed for therapeutic products.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Molecular Infusions
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Molecular Infusions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Molecular Infusions Comparisons
Competitors of Molecular Infusions
Molecular Infusions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sanity Group, ZYUS Life Sciences, Terraflos, Avicanna and Tetra Bio-Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| domain | founded_year | HQ Location |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| domain | founded_year | HQ Location |
Medical cannabis products are provided based on GMP processes.
|
|
| domain | founded_year | HQ Location |
Plant-derived cannabinoid products are developed for medical and consumer uses.
|
|
| domain | founded_year | HQ Location |
Natural medicinal plant-based elements are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Manufacturer of medicinal cannabis for therapeutic use
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Molecular Infusions
When was Molecular Infusions founded?
Molecular Infusions was founded in 2016.
Where is Molecular Infusions located?
Molecular Infusions is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
What does Molecular Infusions do?
Molecular Infusions was founded in 2016 in Los Angeles, United States. Operations are centered in the biotechnology sector, where cannabis-derived pharmaceuticals are developed to address various disorders. Cannabinoid-based formulations for oral, inhalation, and topical use are provided, along with delivery systems designed for therapeutic applications. Focus is placed on advancing treatments through these methods, with activities based in the U.S. healthcare innovation landscape.
Who are the top competitors of Molecular Infusions?
Molecular Infusions's top competitors include Avicanna, ZYUS Life Sciences and Sanity Group.
Who are Molecular Infusions's investors?
Molecular Infusions has 1 investor. Key investors include Surterra.